Safety and Immunogenicity of the rVSV ΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Years and in Their Adults and/or Children Relatives Living in Lambaréné, Gabon

Condition:   Ebola Virus Disease Intervention:   Biological: rVSVΔG-ZEBOV-GP, V920 Sponsors:   Centre de Recherche Médicale de Lambaréné;   Merck Sharp & Dohme Corp. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials